• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes.卓越心脏代谢中心：2型糖尿病心血管疾病二级预防的新型护理模式
Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e007682. doi: 10.1161/CIRCOUTCOMES.120.007682. Epub 2021 Sep 30.
2
Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes Society.2 型糖尿病的心血管疾病防治管理。意大利糖尿病学会专家意见。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1926-1936. doi: 10.1016/j.numecd.2020.07.012. Epub 2020 Jul 18.
3
Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease.糖尿病及其心血管并发症：对一种古老疾病的新见解。
J Diabetes Res. 2019 May 19;2019:1905194. doi: 10.1155/2019/1905194. eCollection 2019.
4
Diabetes: Time for reconciliation between cardiologists and diabetologists.糖尿病：心脏病专家与糖尿病专家和解的时候了。
Nat Rev Cardiol. 2016 Sep;13(9):509-10. doi: 10.1038/nrcardio.2016.113. Epub 2016 Jul 14.
5
Addressing Cardiovascular Risk in Diabetes: It's More Than the Sugar.应对糖尿病中的心血管风险：不止于血糖。
Circulation. 2023 Jun 20;147(25):1887-1890. doi: 10.1161/CIRCULATIONAHA.123.065090. Epub 2023 Jun 19.
6
Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.血清分泌型卷曲相关蛋白 5（SFRP5）水平与多种心血管代谢危险因素呈负相关：KORA F4 研究。
Cardiovasc Diabetol. 2017 Aug 29;16(1):109. doi: 10.1186/s12933-017-0591-x.
7
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).卡格列净用于心血管事件的一级和二级预防：来自 CANVAS 项目（卡格列净心血管评估研究）的结果。
Circulation. 2018 Jan 23;137(4):323-334. doi: 10.1161/CIRCULATIONAHA.117.032038. Epub 2017 Nov 13.
8
Reducing cardiovascular risk in type 2 diabetes: Let's use all we have!降低2型糖尿病患者的心血管疾病风险：让我们充分利用现有资源！
Int J Cardiol. 2020 Jul 1;310:155-156. doi: 10.1016/j.ijcard.2020.04.014. Epub 2020 Apr 13.
9
High Blood Pressure During Pregnancy and Development of Risk Factors for Cardiovascular Disease.孕期高血压与心血管疾病危险因素的发展
Ann Intern Med. 2018 Aug 21;169(4). doi: 10.7326/P18-0008. Epub 2018 Jul 3.
10
Editorial: Precursors of Cardiovascular Disease in Adolescent Type 1 Diabetes.社论：青少年1型糖尿病患者心血管疾病的前驱因素
Curr Diabetes Rev. 2017;13(6):519. doi: 10.2174/157339981306171011155437.

引用本文的文献

1
Impact of sleep apnea treatment on cardiometabolic parameters in a large national multicenter alliance registry.睡眠呼吸暂停治疗对一个大型全国多中心联盟登记处心脏代谢参数的影响。
Am J Prev Cardiol. 2025 Jul 22;23:101062. doi: 10.1016/j.ajpc.2025.101062. eCollection 2025 Sep.
2
Overcoming Disparities in Using SGLT2 Inhibitors for Cardiorenal Protection in Persons With and Without Type 2 Diabetes.克服在使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂对有和没有2型糖尿病的人群进行心肾保护方面的差异。
J Clin Endocrinol Metab. 2025 Aug 7;110(9):e2852-e2863. doi: 10.1210/clinem/dgaf301.
3
Association between dietary inflammatory index score and cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES.饮食炎症指数评分与心血管-肾脏-代谢综合征之间的关联：一项基于美国国家健康与营养检查调查（NHANES）的横断面研究
Front Nutr. 2025 May 9;12:1557491. doi: 10.3389/fnut.2025.1557491. eCollection 2025.
4
The Impact of Obesity on Cardiovascular Diseases: Heart Failure.肥胖对心血管疾病的影响：心力衰竭
Methodist Debakey Cardiovasc J. 2025 Feb 18;21(2):44-52. doi: 10.14797/mdcvj.1511. eCollection 2025.
5
Conceptualising Centres of Clinical Excellence: A Scoping Review.临床卓越中心的概念化：一项范围综述
BMJ Open. 2024 Dec 20;14(12):e082704. doi: 10.1136/bmjopen-2023-082704.
6
Population Health Management and Guideline-Concordant Care in CKD: A Secondary Analysis of Kidney Coordinated HeAlth Management Partnership.慢性肾脏病中的人群健康管理与指南一致性照护：肾脏协调健康管理伙伴关系的二次分析
J Am Soc Nephrol. 2025 May 1;36(5):869-881. doi: 10.1681/ASN.0000000544. Epub 2024 Nov 1.
7
Role and impact of a specialized cardiometabolic clinic in managing high-risk patients with type 2 diabetes and atherosclerotic cardiovascular disease.一家专业的心脏代谢诊所在管理2型糖尿病和动脉粥样硬化性心血管疾病高危患者中的作用和影响。
Am J Prev Cardiol. 2024 Jul 1;19:100706. doi: 10.1016/j.ajpc.2024.100706. eCollection 2024 Sep.
8
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial.ProtecT-2-D 试验方案：在心脏代谢门诊对患有 2 型糖尿病和已确诊的心脏和/或血管疾病的患者进行心血管保护的随机对照试验。
Cardiovasc Diabetol. 2024 Jul 8;23(1):241. doi: 10.1186/s12933-024-02340-w.
9
Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications.跨专业共识对慢性肾脏病（CKD）患者的最佳管理结果：从筛查到并发症。
BMJ Open. 2024 Mar 7;14(3):e080891. doi: 10.1136/bmjopen-2023-080891.
10
Second-year results from CINEMA: A novel, patient-centered, team-based intervention for patients with Type 2 diabetes or prediabetes at high cardiovascular risk.CINEMA研究的第二年结果：一种针对心血管疾病高风险的2型糖尿病或糖尿病前期患者的新型、以患者为中心、基于团队的干预措施。
Am J Prev Cardiol. 2023 Dec 21;17:100630. doi: 10.1016/j.ajpc.2023.100630. eCollection 2024 Mar.

本文引用的文献

1
Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭患者的指南导向的医学治疗的远程优化。
JAMA Cardiol. 2020 Dec 1;5(12):1430-1434. doi: 10.1001/jamacardio.2020.3757.
2
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.美国一大群2型糖尿病患者中心血管疾病的患病率及抗糖尿病治疗特征。
Endocrinol Diabetes Metab. 2019 May 22;2(3):e00076. doi: 10.1002/edm2.76. eCollection 2019 Jul.
3
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease.糖尿病和动脉粥样硬化性心血管疾病患者中指南推荐的风险降低策略的应用
Circulation. 2019 Aug 13;140(7):618-620. doi: 10.1161/CIRCULATIONAHA.119.041730. Epub 2019 Jun 7.
4
10. Cardiovascular Disease and Risk Management: .10. 心血管疾病与风险管理： 。
Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123. doi: 10.2337/dc19-S010.
5
Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry.糖尿病协作登记处初始患者队列的护理质量。
J Am Heart Assoc. 2017 Aug 11;6(8):e005999. doi: 10.1161/JAHA.117.005999.
6
Effect of a multifactorial intervention on mortality in type 2 diabetes.多因素干预对2型糖尿病患者死亡率的影响。
N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245.

Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes.

作者信息

Thomas Merrill, Magwire Melissa, Gosch Kensey, Sammour Yasser, Mehta Rane, O'Keefe James, Nassif Michael E, Kosiborod Mikhail

机构信息

Saint Luke's Mid America Heart Institute, Kansas City, MO (M.T., M.M., K.G., R.M., J.O., M.E.N., M.K.).

University of Missouri-Kansas City School of Medicine (M.T., Y.S., J.O., M.E.N., M.K.).

出版信息

Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e007682. doi: 10.1161/CIRCOUTCOMES.120.007682. Epub 2021 Sep 30.

DOI:10.1161/CIRCOUTCOMES.120.007682
PMID:34587753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8530947/
Abstract
摘要